IM
ImageneBio Inc (IMA)
NASDAQ·Healthcare·Biotechnology
$5.00
-0.10%
Mkt Cap $66.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
Implied Upside
-73.4%
Consensus $1.33 vs current $5.00
NASDAQ·Healthcare·Biotechnology
$5.00
-0.10%
Mkt Cap $66.20M
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
-73.4%
Consensus $1.33 vs current $5.00